Literature DB >> 23800944

miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.

Baofei Jiang1, Zengliang Li, Wenjie Zhang, Haixiao Wang, Xiaofei Zhi, Jin Feng, Zheng Chen, Yi Zhu, Li Yang, Hao Xu, Zekuan Xu.   

Abstract

BACKGROUND: Aquaporin-3 (AQP3) is a water transporting protein which plays an oncogenic role in several malignant tumors. However, its regulatory mechanism remains elusive to date. In this study, we investigated the microRNA-mediated gene repression mechanism involved in AQP3's role.
METHODS: The potential microRNAs targeting AQP3 were searched via bioinformatic methods and identified by luciferase reporter assays, microRNA RT-PCR and western blotting. The expression patterns of miR-874 and AQP3 in human gastric cancer (GC) specimens and cell lines were determined by microRNA RT-PCR and western blotting. 5-ethynyl-2'-deoxyuridine, cell migration and invasion assays and tumorigenicity in vivo were adopted to observe the effects of miR-874 depletion or ectopic miR-874 expression on GC cell phenotypes. Cell apoptosis was evaluated by FACS and TUNEL in vitro and in vivo respectively.
RESULTS: miR-874 suppressed AQP3 expression by binding to the 3'UTR of AQP3 mRNA in GC cells. miR-874 was significantly down-regulated and reversely correlated with AQP3 protein levels in clinical samples. Analysis of the clinicopathological significance showed that miR-874 and AQP3 were closely correlated with GC characteristics. Functional analyses indicated that ectopic miR-874 expression suppressed the growth, migration, invasion and tumorigenicity of GC cells, whereas miR-874 knockdown promoted these phenotypes. Down-regulation of Bcl-2, MT1-MMP, MMP-2 and MMP-9 and upregulation of caspase-3 activity and Bax were involved in miR-874 inducing cell apoptosis, and inhibiting migration and invasion.
CONCLUSIONS: These results provide a mechanism by which AQP3 is upregulated, as well as highlight the importance of miR-874 in gastric cancer development and progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800944     DOI: 10.1007/s00535-013-0851-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  32 in total

Review 1.  Roles for novel pharmacological blockers of aquaporins in the treatment of brain oedema and cancer.

Authors:  Andrea J Yool; Elizabeth A Brown; Gary A Flynn
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

2.  Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3.

Authors:  Weijun Liu; Kunhua Wang; Kunmei Gong; Xiaogang Li; Kaiyuan Luo
Journal:  Mol Med Rep       Date:  2012-06-25       Impact factor: 2.952

3.  Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues.

Authors:  Ya Lan Liu; Toshiyuki Matsuzaki; Tadao Nakazawa; Shin-Ichi Murata; Nobuki Nakamura; Tetsuo Kondo; Masanori Iwashina; Kunio Mochizuki; Tetsu Yamane; Kuniaki Takata; Ryohei Katoh
Journal:  Hum Pathol       Date:  2006-10-23       Impact factor: 3.466

4.  EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration.

Authors:  Cong Cao; Yun Sun; Sarah Healey; Zhigang Bi; Gang Hu; Shu Wan; Nicola Kouttab; Wenming Chu; Yinsheng Wan
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

5.  Collecting duct carcinoma: an entity to be redefined?

Authors:  Hélène Kafé; Jean-Marc Verbavatz; Béatrix Cochand-Priollet; Patrice Castagnet; Annick Vieillefond
Journal:  Virchows Arch       Date:  2004-10-08       Impact factor: 4.064

6.  EdU, a new thymidine analogue for labelling proliferating cells in the nervous system.

Authors:  Fatemah Chehrehasa; Adrian C B Meedeniya; Patrick Dwyer; Greger Abrahamsen; Alan Mackay-Sim
Journal:  J Neurosci Methods       Date:  2008-10-18       Impact factor: 2.390

7.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

9.  Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.

Authors:  N Nohata; T Hanazawa; N Kikkawa; D Sakurai; L Fujimura; T Chiyomaru; K Kawakami; H Yoshino; H Enokida; M Nakagawa; A Katayama; Y Harabuchi; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

10.  Reference miRNAs for miRNAome analysis of urothelial carcinomas.

Authors:  Nadine Ratert; Hellmuth-Alexander Meyer; Monika Jung; Hans-Joachim Mollenkopf; Ina Wagner; Kurt Miller; Ergin Kilic; Andreas Erbersdobler; Steffen Weikert; Klaus Jung
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

View more
  43 in total

1.  MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.

Authors:  Y-Q Shan; R-C Ying; C-H Zhou; A-K Zhu; J Ye; W Zhu; T-F Ju; H-C Jin
Journal:  Cancer Gene Ther       Date:  2015-01-30       Impact factor: 5.987

Review 2.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

3.  miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.

Authors:  Ronglin Zhai; Xuefeng Kan; Bo Wang; Hansong Du; Yueping Long; Heshui Wu; Kaixiong Tao; Guobin Wang; Lihong Bao; Fen Li; Wanli Zhang
Journal:  Tumour Biol       Date:  2014-08-15

Review 4.  Cellular physiological approach for treatment of gastric cancer.

Authors:  Atsushi Shiozaki; Daisuke Ichikawa; Eigo Otsuji; Yoshinori Marunaka
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  CEP55 contributes to human gastric carcinoma by regulating cell proliferation.

Authors:  Jinqiu Tao; Xiaofei Zhi; Yuan Tian; Zheng Li; Yi Zhu; Weizhi Wang; Kunling Xie; Jie Tang; Xiaoyu Zhang; Linjun Wang; Zekuan Xu
Journal:  Tumour Biol       Date:  2014-01-04

6.  A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.

Authors:  Shan-Shan Liu; Eithne Margaret Maguire; Yin-Shan Bai; Li Huang; Yurong Liu; Liping Xu; Iliana Fauzi; Shou-Quan Zhang; Qingzhong Xiao; Ning-Fang Ma
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

7.  miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3.

Authors:  Dong Dong; Yubao Gong; Debao Zhang; Huricha Bao; Guishan Gu
Journal:  Tumour Biol       Date:  2015-12-02

Review 8.  Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Authors:  Shan-Shan Xie; Juan Jin; Xiao Xu; Wei Zhuo; Tian-Hua Zhou
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

9.  MicroRNA-874-mediated inhibition of the major G1/S phase cyclin, CCNE1, is lost in osteosarcomas.

Authors:  Tanushree Ghosh; Akhil Varshney; Praveen Kumar; Manpreet Kaur; Vipin Kumar; Ritu Shekhar; Raksha Devi; Priyanka Priyanka; Md Muntaz Khan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

10.  MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12.

Authors:  Tao Jiang; Lian-Yue Guan; Yan-Shuo Ye; Hong-Yu Liu; Rui Li
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.